QA: Organon Co in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001821825_2026_Organon_Co.pdf

Logs

Graph

Absolute values for 0001821825, Organon Co

  xvar xval
0 AssetsCurrent 4,352,000,000
1 IntangibleAssetsNetIncludingGoodwill 5,283,000,000
2 PropertyPlantAndEquipmentNet 1,303,000,000
3 remainder_Assets 1,929,000,000
4 LiabilitiesCurrent 2,390,000,000
5 LiabilitiesNoncurrent 9,636,000,000
6 remainder_Liabilities 89,000,000
7 CostOfGoodsAndServicesSold 2,897,415,741
8 SellingGeneralAndAdministrativeExpense 1,720,344,185
9 ResearchAndDevelopmentExpense 356,795,733
10 remainder_Expenses 1,158,107,095
11 remainder_Revenues 6,219,887,419
12 remainder_NetIncome -46,940,724
13 remainder_ComprehensiveNetIncome -107,750,422
  yvar yval
0 Assets 12,867,000,000
1 Liabilities 12,115,000,000
2 Expenses 6,132,662,754
3 Revenues 6,219,887,419
4 StockholdersEquity 752,000,000
5 NetIncome 40,283,941
6 ComprehensiveNetIncome -13,591,270
7 BaseVar 18,744,620,660
8 EconomicCapitalRatiobeforeLimitedLiability 0.130
9 EconomicCapitalRatio 1.54

Edgar->Model Mapping

Feature Distribution

Change over Time